Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coiffier

Showing results (11-20 of 289) with videos related to

Pageof 29
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Prognostic factors in malignant lymphomasB Coiffier
Pathologie-Biologie|January 1, 1987
[Contribution of anthracyclines in treatment of lymphoproliferative disorders]B Coiffier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Which treatment for mantle-cell lymphoma patients in 1998?B Coiffier
Seminars in Oncology|November 24, 1999
Treatment of aggressive non-Hodgkin's lymphomaB Coiffier
Haematologica|July 25, 2000
Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patientsB Coiffier
Bulletin Du Cancer|December 23, 2000
[Monoclonal antibodies in the treatment of neoplastic hematologic diseases]B Coiffier
Nouvelle Revue Francaise D'Hematologie|June 1, 1993
[Therapeutic strategies in malignant non-Hodgkin's lymphoma in adults]B Coiffier
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Fourteen years of high-dose CHOP (ACVB regimen): preliminary conclusions about the treatment of aggressive-lymphoma patients. Hamilton Fairley Award Lecture, European Society for Medical Oncology Meeting, Lisbon, November 21, 1994B Coiffier
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Interferon alpha-recombinant in the treatment of follicular lymphoma patientsB Coiffier
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
How should prognostic factors influence therapy in follicular lymphomas?B Coiffier
Pageof 29

Showing results (11-20 of 289) with videos related to

Sort By:
Pageof 29
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Prognostic factors in malignant lymphomasB Coiffier
Pathologie-Biologie|January 1, 1987
[Contribution of anthracyclines in treatment of lymphoproliferative disorders]B Coiffier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Which treatment for mantle-cell lymphoma patients in 1998?B Coiffier
Seminars in Oncology|November 24, 1999
Treatment of aggressive non-Hodgkin's lymphomaB Coiffier
Haematologica|July 25, 2000
Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patientsB Coiffier
Bulletin Du Cancer|December 23, 2000
[Monoclonal antibodies in the treatment of neoplastic hematologic diseases]B Coiffier
Nouvelle Revue Francaise D'Hematologie|June 1, 1993
[Therapeutic strategies in malignant non-Hodgkin's lymphoma in adults]B Coiffier
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Fourteen years of high-dose CHOP (ACVB regimen): preliminary conclusions about the treatment of aggressive-lymphoma patients. Hamilton Fairley Award Lecture, European Society for Medical Oncology Meeting, Lisbon, November 21, 1994B Coiffier
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Interferon alpha-recombinant in the treatment of follicular lymphoma patientsB Coiffier
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
How should prognostic factors influence therapy in follicular lymphomas?B Coiffier
Pageof 29